Business Context and Reporting Period
Company: Primerica, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Primerica is a leading provider of financial products and services to middle-income households in the U.S. and Canada. The company operates through three segments: Term Life Insurance (underwritten), Investment and Savings Products (distributed), and Corporate and Other Distributed Products. It utilizes a network of approximately 151,524 independent sales representatives as of year-end 2025.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenues | $3,291.7 million | $3,089.1 million | +7% |
| Net Income | $751.2 million | $470.5 million | +60% |
| Diluted EPS | $22.91 | $13.71 | +67% |
| Operating Cash Flow | $901.2 million | $862.1 million | +5% |
| Total Assets | $15,012.3 million | $14,582.0 million | +3% |
| Stockholders' Equity | $2,445.9 million | $2,259.0 million | +8% |
| Debt (Senior Notes) | $600.0 million | $600.0 million | 0% |
Note: 2024 Net Income included a significant loss from discontinued operations ($249.6 million) related to the Senior Health business, which was disposed of in September 2024. 2025 Net Income reflects only continuing operations.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 7% year-over-year, driven by an 18% increase in commissions and fees from the Investment and Savings Products segment and a 3% increase in net premiums from the Term Life Insurance segment.
- Profitability Surge: Net income increased 60% primarily due to the absence of the discontinued operations loss recorded in 2024 and a one-time $50.0 million gain recognized in 2024 from a representation and warranty insurance policy that did not recur in 2025.
- Segment Performance:
- Term Life Insurance: Income before taxes rose 3% to $621.1 million. New policies issued decreased to 331,787 (from 370,396 in 2024), but the in-force face amount grew to $967.6 billion.
- Investment and Savings Products: Income before taxes rose 18% to $355.5 million, fueled by strong equity market performance and increased asset values ($128.9 billion at year-end).
- Discontinued Operations: The Senior Health business was fully divested in 2024. No results from this segment are reported in 2025.
Guidance, Outlook, and Risks
Management Commentary:
- Market Conditions: Strong equity market performance in 2025 benefited the Investment and Savings Products segment. However, elevated cost-of-living pressures continue to impact persistency in the Term Life Insurance segment, though lapse rates have stabilized compared to prior years.
- Capital Allocation: The company repurchased $450.0 million of common stock in 2025 under a program that expired in December 2025. A new $475.0 million repurchase program was authorized in November 2025.
- Dividends: The company declared a quarterly dividend of $1.20 per share in Q1 2026 and expects to continue paying comparable quarterly cash dividends.
Key Risks and Contingencies:
- Distribution Model: Reliance on independent contractors creates risks regarding worker classification (employee vs. contractor) and regulatory scrutiny of recruiting practices.
- Reinsurance: The company reinsures 80-90% of mortality risk. Failure of reinsurers to perform obligations could materially impact results.
- Regulatory Environment: Changes in insurance, securities, and mortgage regulations (including "best interest" standards and climate change reporting) could increase compliance costs or restrict product offerings.
- Interest Rates: Fluctuations in interest rates impact the fair value of the invested asset portfolio and the cost of debt.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the comparability of 2025 net income to 2024 by excluding the $249.6 million loss from the Senior Health business disposal in 2024.
- One-Time Gains: Confirm the impact of the $50.0 million R&W insurance gain in 2024 on prior year profitability comparisons.
- Reinsurance Concentration: Review Note 7 for the concentration of reinsurance recoverables with specific counterparties (e.g., Swiss Re, Munich Re) and their credit ratings.
- Actuarial Assumptions: Examine Note 11 for changes in mortality, lapse, and disability assumptions that drove the $37.4 million remeasurement gain in 2025.
- Share Repurchase Authority: Confirm the status of the new $475.0 million share repurchase program authorized in late 2025.